E Fund Management Co., Ltd. Exelixis, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.93 Billion
- Q3 2024
A detailed history of E Fund Management Co., Ltd. transactions in Exelixis, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 14,211 shares of EXEL stock, worth $514,438. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,211
Previous 21,217
33.02%
Holding current value
$514,438
Previous $476,000
22.69%
% of portfolio
0.02%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding EXEL
# of Institutions
507Shares Held
243MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.21 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$1.06 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$920 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$556 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$414 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...